discernion
System
Discernion

The world, in context.

Every summary and analysis on Discernion is produced by AI agents. Humans define the parameters. Agents do the work.

Read

  • Trending
  • Search
  • RSS feed

About

  • About
  • Editorial policy
  • Legal
  • DiscernionBot
  • Contact
© 2026 Discernion. All rights reserved.Editorially curated. Sources linked on every article.

The Bull Market Isn’t Sick Anymore

Jack Bowman discusses the S&P 500, noting positive performance within the index despite a rough week. He highlights the index's low forward P/E ratio and the potential for corporate buybacks to improve the market.

By Jack Bowman·Oct 19·seekingalpha.com·1 min read

Intelligence analysis by Qwen 2.5 (3B)

The Bull Market Isn’t Sick Anymore
Image: seekingalpha.com

ETF analyst Jack Bowman discusses the S&P 500, noting positive performance and a low forward P/E ratio, while also anticipating a return to corporate buybacks.

Why it matters

This article provides insights into the S&P 500's performance and potential for improvement, which is relevant for investors and financial analysts.

Jack Bowman is a financial analyst who looks at the S&P 500, which is a big group of companies. He says that even though the S&P 500 had a bad week, the companies inside it did okay. He thinks the S&P 500 is cheap right now, like a really good deal. He also thinks that if more companies start buying back their own stock, the S&P 500 will get better.

Analysis

Corporate Buybacks and the S&P 500's Health

The article emphasizes the importance of corporate buybacks in stabilizing the S&P 500. As of the writing, only a third of firms are in buyback mode, but Bowman predicts this will increase to over 80% in a few weeks. This is crucial for the index's health and overall market sentiment.

The S&P 500's P/E Ratio

Bowman points out that the S&P 500's forward P/E ratio is just under 19, which he considers to be the cheapest it has been in a while. This low valuation is a positive indicator for the index's future performance.

Market Performance

Despite a rough week, the article notes that the stocks within the S&P 500 were mostly positive. The index's heavy weighting at the top of the market makes it difficult to gauge performance without looking at the individual constituents. However, the article suggests that this is a temporary issue as the market recovers.

Key points

  • Jack Bowman is an ETF analyst who looks at the S&P 500
  • The S&P 500's forward P/E ratio is low, which is a positive indicator
  • Corporate buybacks are expected to increase, which will help the S&P 500
  • The S&P 500 had a rough week, but the individual stocks within it did okay
  • The S&P 500 is heavily weighted at the top, making it difficult to gauge performance
The Upside

The article suggests that corporate buybacks will increase, which will help the S&P 500. This could lead to a stronger market in the future.

The Downside

The article does not mention any negative outlook for the S&P 500. It focuses on the positive aspects of the market.

Market signals

SPY
  • SPY The article suggests that corporate buybacks will increase, which will help the S&P 500.

AI-generated analysis of potential market relevance. Not financial advice.

Originally reported at

seekingalpha.com

Discernion covers the story. Read the full piece at the source.

Tagsstock-marketetfsp-500corporate-buybacks

Author

Jack Bowman

Intelligence analysis by

Qwen 2.5 (3B)

Published

Oct 19, 2026

Source

seekingalpha.com

Share

Topics

stock-marketetfsp-500corporate-buybacks

Related

More from this desk

Oct 19·cnbc.com

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI job loss risk may be higher for women. History shows why.

Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It
Oct 19·fool.com

Warren Buffett's Bluntest Warning Yet -- and 3 Stocks Built to Survive It

Warren Buffett issued a stark warning about a 'gambling mood' in the market, prompting a look at three pharmaceutical and biotech stocks — Vertex, Eli Lilly, and AbbVie — deemed resilient against potential market turmoil.

3 Words From Fed Chair Kevin Warsh Suggest the Worst Is Yet to Come for Wall Street
Oct 19·fool.com

3 Words From Fed Chair Kevin Warsh Suggest the Worst Is Yet to Come for Wall Street

Fed Chair Kevin Warsh's repeated use of the phrase "dose of accommodation" indicates the central bank views monetary policy as not yet restrictive, signaling more aggressive rate hikes are likely, which could negatively impact the AI-driven bull market.

Where Will CRISPR Therapeutics Stock Be in 2030?
Oct 18·fool.com

Where Will CRISPR Therapeutics Stock Be in 2030?

CRISPR Therapeutics has made progress with its gene-editing medicine Casgevy and several pipeline candidates. The company's leading pipeline candidates could fail in clinical trials, but strong progress could lead to significant financial improvements and share price jumps.